DFD, Ophthalmology Foundation join forces for $200M research effort to improve vision
DFD has agreed to join forces with the Ophthalmologists’ Foundation to create a $200 million fund to invest in research to improve the vision of patients with cataracts, glaucoma and other vision disorders.
The DFD will invest in “significant new research projects” aimed at improving vision and reducing the need for surgery, DFD said in a statement on Tuesday.DFD and Ophthalmic Foundation announced in April that they would create the Vision Vision Foundation, a $100 million investment fund to fund innovative research into vision and related medical conditions.
DFD and the OVAF, which focuses on glauco-optic and corneal disorders, have pledged to invest $100 billion in new treatments for the vision disorders by 2025.
The Vision Vision Fund will focus on research into the causes of vision loss, and will work with existing and emerging medical centers to identify innovative approaches to treat vision loss in the U.S.
A new program will allow the DFD to apply for patents related to vision loss-related treatment, which is typically the result of a device that is surgically implanted.
The $200m fund will be divided between research and clinical development programs, according to DFD.
The partnership comes as DFD prepares to expand its global vision care network with additional centers in China, India, the United Arab Emirates and Pakistan, and a new $150 million, five-year fund that will focus primarily on vision care and the vision industry.DFLA, which has more than 1.2 million members worldwide, is a nonprofit research and educational organization that seeks to improve eyesight worldwide through research and education.